Stay updated on IMGN632 in BPDCN Clinical Trial
Sign up to get notified when there's something new on the IMGN632 in BPDCN Clinical Trial page.
Latest updates to the IMGN632 in BPDCN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a PubMed auto-fill note for publications and updated the page revision to v3.3.2; the previous PubMed description and the older revision v3.2.0 were removed.SummaryDifference0.1%
- Check19 days agoChange DetectedThe government funding status notice was removed, but the study details remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check33 days agoChange DetectedLayout and formatting changes to the study page, with no modification to core content such as title, conditions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check62 days agoChange DetectedUpdated version to v3.2.0 and added government operating-status notice; removed a previously listed condition (CD4+/CD56+ hematodermic neoplasm) and prior version tag. Overall: core content update plus new operational status info.SummaryDifference4%
- Check69 days agoChange DetectedCore terminology and versioning updated: replacing 'Acute lymphoblastic leukemia' with 'Acute lymphoid leukemia' and bumping the revision from v3.0.2 to v3.1.0.SummaryDifference0.2%
- Check84 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%
Stay in the know with updates to IMGN632 in BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN632 in BPDCN Clinical Trial page.